Article info
Correspondence response
Differentiation between various Chondroitin sulfate formulations in symptomatic knee osteoarthritis
- Correspondence to Professor Jean Yves Reginster, Public Health, Epidemiology and Health Economics, WHO Collaborating Center for Public Health aspects of muskulo-skeletal health and aging, University of Liege-4020, Liege, Belgium; jyreginster{at}ulg.ac.be
Citation
Differentiation between various Chondroitin sulfate formulations in symptomatic knee osteoarthritis
Publication history
- Received October 20, 2017
- Accepted October 22, 2017
- First published November 1, 2017.
Online issue publication
October 18, 2019
Article Versions
- Previous version (18 October 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.